Report Overview

The Germany and Netherlands Medical Marijuana market size stood at around USD 977.7 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.



Medical marijuana, which is also known as medical cannabis is a term used for the derivatives of the Cannabis sativa plant that are used for medicinal purposes to treat serious or chronic symptoms. It may be used for varied symptoms such as pain, anxiety, muscle spasms, epilepsy and more.

Netherlands was the 3^rd largest market for medical marijuana in Europe in 2018. In 2015, the Netherlands medical marijuana market size was USD 6.1 million. About 550 of cannabis flower were sold in 2018, with an estimated retail value of USD 3.8 million.

Between 2017 and 2018, the number of dispensing medical cannabis dropped by 7% from 53,300 to 49,500 dispensations. This may be because in 2018, the Dutch College of General Practitioners advised doctors to show restraint in prescribing medical marijuana. The decrease is also related to the non-reimbursement by insurance companies.



 

Market Drivers

In Netherlands, Bedrocan is the sole producer of medicinal cannabis and distributor to the Dutch pharmacies. In 2019, an application was filed for selection of new growers and producers. Many North American companies are expected to apply for the same. This will act as a market driver.

Medical marijuana is increasingly being legalized around the world. It is being used to manage symptoms of chronic illnesses and pain. There is increased awareness and acceptance among patients, which will act as a market driver.

In Netherlands, medical marijuana use is permitted for cancer patients. Netherlands has one of the highest and an ever-increasing burden of cancer in Europe. This is also expected to fuel the market.